What does CUSIP 92764N102 represent in this 13F holders report?

CUSIP 92764N102 is the security identifier for VIR - Vir Biotechnology, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held VIR - Vir Biotechnology, Inc. - COMMON STOCK in Q1 2022?

191 institutional investors reported VIR - Vir Biotechnology, Inc. - COMMON STOCK for Q1 2022. Use the holders table for investor-level position and value details.

Vir Biotechnology, Inc. - COMMON STOCK (VIR)

CUSIP: 92764N102

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / COMMON STOCK
Total 13F shares: 81,103,450
Total 13F value: $2,086,374,530
Share change: +3,023,477
Put/Call ratio: 66%
SEC-reported price per share: $25.72
Number of holders: 191
Value change: -$14,155,763
Number of buys: 123
Number of sells: 89
Shares outstanding: 168,883,915

Security key

92764N102

Report period

Q1 2022

Institutions

191

Top holders

VIR full security history Ownership snapshot Full 13F holder table Vir Biotechnology, Inc. SEC filings Vir Biotechnology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of VIR - Vir Biotechnology, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SB INVESTMENT ADVISERS (U...

Disclosed value leader

SB INVESTMENT ADVISERS (U...

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.

Comparable ownership Top 5

SB INVESTMENT ADVISERS (UK) LTD 13%

VANGUARD GROUP INC 4.3%

Temasek Holdings (Private) Ltd 3.3%

Capital International Investors 3.3%

BlackRock Finance, Inc. 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SB INVESTMENT ADVISERS (UK) LTD	13F Company 13F	13%	$930,211,000 22,216,644 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	4.3%	$306,913,000 7,330,131 shares	—	31 Dec 2021
Temasek Holdings (Private) Ltd	13F Company 13F	3.3%	$231,846,000 5,537,291 shares	—	31 Dec 2021
Capital International Investors	13F Company 13F	3.3%	$230,518,000 5,505,566 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	3.1%	$222,248,000 5,308,049 shares	—	31 Dec 2021
BAILLIE GIFFORD & CO	13F Company 13F	2.3%	$163,942,000 3,915,501 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

191

81,103,450

Rows available

191

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

191

Q1 2022 holders

191

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %